Dr. Frederich is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1030 S Broadway
Suite 5
Lexington, KY 40504Phone+1 859-257-4058
Education & Training
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1988 - 1991
University of North Carolina HospitalsResidency, Internal Medicine, 1984 - 1987
University of Colorado School of Medicine Anschutz Medical CampusClass of 1984
Certifications & Licensure
KY State Medical License 1997 - 2025
NC State Medical License 1987 - 1995- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 43 citationsSaxagliptin improves glycaemic control and C‐peptide secretion in latent autoimmune diabetes in adults (LADA)Raffaella Buzzetti, Paolo Pozzilli, Robert Frederich, Nayyar Iqbal, Boaz Hirshberg
Diabetes/metabolism Research and Reviews. 2016-03-01 - 29 citationsResponse to Letter Regarding Article, “Heart Failure, Saxagliptin and Diabetes Mellitus: Observations From the SAVOR-TIMI 53 Randomized Trial”Benjamin M. Scirica, Eugene Braunwald, Itamar Raz, Matthew A. Cavender, David A. Morrow
Circulation. 2015-08-11 - 69 citationsEfficacy and Safety of Saxagliptin in Older Participants in the SAVOR-TIMI 53 TrialLawrence A. Leiter, Hwee Teoh, Eugene Braunwald, Ofri Mosenzon, Avivit Cahn
Diabetes Care. 2015-06-01
Journal Articles
- Cardiovascular Outcomes with Ertugliflozin in Type 2 DiabetesSamuel Dagogo-Jack, Urszula Masiukiewicz, Robert Frederich, Darren K Mcguire, The New England Journal of Medicine
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
